A Phase I, Open-label, Randomized, 2-Way Crossover Study to Evaluate the Relative Bioavailability of Intranasal and Oral Varenicline
Jeffrey Nau, D.J. Wyatt, Hans Rollema, Christopher Crean
Topics & Concepts
VareniclineCmaxMedicineNasal administrationBioavailabilityPharmacokineticsPharmacologyCrossover studyTolerabilityNasal sprayAnesthesiaAdverse effectInternal medicinePlaceboNicotineAlternative medicinePathologyOcular Surface and Contact LensGlaucoma and retinal disordersRetinal Diseases and Treatments